Home › Asset managers › Compare 2025-2026 › TIAA vs Brighthouse
Note on Brighthouse: its funds did not all vote the same way on 12.0% of the 120,248 ballot items it voted. Those items are not in the percentage above; the ones it shares with this pair are listed under “Split votes”.
TIAA 2025-2026 · Brighthouse 2025-2026 · Download the item list (CSV)
| Common items | Same | Differ | Split (not in %) | Same position | Fund-level | |
|---|---|---|---|---|---|---|
| All ballot items | 58,772 | 44,349 | 3,418 | 11,005 | 92.8% | 87.0% |
| Board proposals | 49,673 | 36,224 | 3,273 | 10,176 | 91.7% | 85.7% |
| E&S shareholder proposals | 173 | 0 | 1 | 172 | 0.0% | 38.4% |
| Other items | 8,926 | 8,125 | 144 | 657 | 98.3% | 94.8% |
Everything Voted differently Split votes
All ballot items Board proposals E&S shareholder proposals Other items
10,176 items. “Voted differently”: each manager’s funds all voted one way, and the two ways differ. “Split”: at least one manager’s funds did not all vote the same way.
| Company | Meeting | Proposal | On the ballot from | Board recommended | TIAA | Brighthouse |
|---|---|---|---|---|---|---|
| AMN Healthcare Services, Inc. | May 1, 2026 | Election of Directors: Teri G. Fontenot Director Elections |
Board | For | FOR 4 funds |
Split 3 FOR, 1 ABSTAIN |
| AMNEAL PHARMACEUTICALS, INC. | May 6, 2026 | Advisory vote to approve executive compensation. Say-on-Pay |
Board | For | FOR 9 funds |
Split 2 FOR, 1 ABSTAIN |
| AMNEAL PHARMACEUTICALS, INC. | May 6, 2026 | Ratification of the appointment of Ernst & Young LLP as independent registered public accounting firm for fiscal 2026. Audit-related |
Board | For | FOR 8 funds |
Split 2 FOR, 1 ABSTAIN |
| AMPHASTAR PHARMACEUTICALS INC. | June 1, 2026 | To approve, on an advisory basis, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 4 funds |
Split 2 FOR, 1 ABSTAIN |
| AMPHASTAR PHARMACEUTICALS INC. | June 1, 2026 | To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for its fiscal year ending December 31, 2026; and Audit-related |
Board | For | FOR 4 funds |
Split 2 FOR, 1 ABSTAIN |
| AMPHENOL CORPORATION | May 21, 2026 | Advisory vote to approve compensation of named executive officers Say-on-Pay |
Board | For | FOR 12 funds |
Split 9 FOR, 1 AGAINST, 6 ABSTAIN |
| AMPHENOL CORPORATION | May 21, 2026 | Ratification of the selection of Deloitte & Touche LLP as independent public accountants Audit-related |
Board | For | FOR 11 funds |
Split 9 FOR, 1 AGAINST, 6 ABSTAIN |
| AMPLITUDE, INC. | June 9, 2026 | The approval, on an advisory (non-binding) basis, of the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 8 funds |
Split 2 FOR, 1 ABSTAIN |
| AMPLITUDE, INC. | June 9, 2026 | The ratification of the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 8 funds |
Split 2 FOR, 1 ABSTAIN |
| AMPRIUS TECHNOLOGIES, INC. | June 11, 2026 | The ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. Audit-related |
Board | Not determined | FOR 4 funds |
Split 1 FOR, 1 ABSTAIN |
| AMRIZE AG | April 21, 2026 | Re-election of Jan Jenisch as Chairman of the Board Corporate Governance |
Board | For | FOR 2 funds |
Split 2 FOR, 2 AGAINST |
| AMYLYX PHARMACEUTICALS, INC. | June 4, 2026 | To approve, on a non-binding, advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 4 funds |
Split 1 FOR, 1 AGAINST, 1 ABSTAIN |
| AMYLYX PHARMACEUTICALS, INC. | June 4, 2026 | To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 4 funds |
Split 2 FOR, 1 ABSTAIN |
| ANALOG DEVICES, INC. | March 11, 2026 | Advisory vote to approve the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 10 funds |
Split 6 FOR, 1 AGAINST, 4 ABSTAIN |
| ANALOG DEVICES, INC. | March 11, 2026 | Approve the Amended and Restated Analog Devices, Inc. 2020 Equity Incentive Plan. Compensation |
Board | For | FOR 9 funds |
Split 7 FOR, 4 ABSTAIN |
| ANALOG DEVICES, INC. | March 11, 2026 | Ratification of the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year 2026. Audit-related |
Board | For | FOR 9 funds |
Split 6 FOR, 1 AGAINST, 4 ABSTAIN |
| ANHEUSER-BUSCH INBEV SA/NV | April 29, 2026 | ACKNOWLEDGE RESIGNATION OF MARTIN J. BARRINGTON AS RESTRICTED SHARE DIRECTOR AND ELECT WILLIAM F. GIFFORD, JR. AS RESTRICTED SHARE DIRECTOR Director Elections |
Board | For | AGAINST 3 funds |
Split 1 FOR, 2 AGAINST |
| ANHEUSER-BUSCH INBEV SA/NV | April 29, 2026 | ACKNOWLEDGE RESIGNATION OF SALVATORE MANCUSO AS RESTRICTED SHARE DIRECTOR AND ELECT JENNIFER HUNTER AS RESTRICTED SHARE DIRECTOR Director Elections |
Board | For | AGAINST 3 funds |
Split 1 FOR, 2 AGAINST |
| ANHEUSER-BUSCH INBEV SA/NV | April 29, 2026 | AUTHORIZE REPURCHASE OF UP TO 20 PERCENT OF ISSUED SHARE CAPITAL Capital Structure |
Board | For | FOR 3 funds |
Split 1 FOR, 2 AGAINST |
| ANHEUSER-BUSCH INBEV SA/NV | April 29, 2026 | REELECT ALEJANDRO SANTO DOMINGO AS RESTRICTED SHARE DIRECTOR Director Elections |
Board | For | AGAINST 3 funds |
Split 1 FOR, 2 AGAINST |
| ANI PHARMACEUTICALS, INC. | May 21, 2026 | To approve the Amended and Restated 2022 Stock Incentive Plan. Compensation |
Board | For | FOR 5 funds |
Split 3 FOR, 1 ABSTAIN |
| ANI PHARMACEUTICALS, INC. | May 21, 2026 | To approve the compensation of the Company's named executive officers, on a non-binding, advisory basis. Say-on-Pay |
Board | For | FOR 5 funds |
Split 3 FOR, 1 ABSTAIN |
| ANI PHARMACEUTICALS, INC. | May 21, 2026 | To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. Audit-related |
Board | For | FOR 5 funds |
Split 3 FOR, 1 ABSTAIN |
| ANI Pharmaceuticals, Inc. | May 21, 2026 | Election of Directors: Antonio R. Pera Director Elections |
Board | For | FOR 5 funds |
Split 3 FOR, 1 ABSTAIN |
| ANI Pharmaceuticals, Inc. | May 21, 2026 | Election of Directors: Jeanne A. Thoma Director Elections |
Board | For | FOR 5 funds |
Split 3 FOR, 1 ABSTAIN |
| ANI Pharmaceuticals, Inc. | May 21, 2026 | Election of Directors: Matthew J. Leonard, R.Ph. Director Elections |
Board | For | FOR 5 funds |
Split 3 FOR, 1 ABSTAIN |
| ANI Pharmaceuticals, Inc. | May 21, 2026 | Election of Directors: Muthusamy Shanmugam Director Elections |
Board | For | FOR 5 funds |
Split 3 FOR, 1 ABSTAIN |
| ANI Pharmaceuticals, Inc. | May 21, 2026 | Election of Directors: Nikhil Lalwani Director Elections |
Board | For | FOR 5 funds |
Split 3 FOR, 1 ABSTAIN |
| ANI Pharmaceuticals, Inc. | May 21, 2026 | Election of Directors: Renee P. Tannenbaum, Pharm.D. Director Elections |
Board | For | FOR 5 funds |
Split 3 FOR, 1 ABSTAIN |
| ANI Pharmaceuticals, Inc. | May 21, 2026 | Election of Directors: Thomas J. Haughey Director Elections |
Board | For | FOR 5 funds |
Split 3 FOR, 1 ABSTAIN |
| ANNALY CAPITAL MANAGEMENT, INC. | June 10, 2026 | Advisory approval of the Company's executive compensation. Say-on-Pay |
Board | For | FOR 6 funds |
Split 3 FOR, 2 ABSTAIN |
| ANNALY CAPITAL MANAGEMENT, INC. | June 10, 2026 | Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 5 funds |
Split 3 FOR, 2 ABSTAIN |
| ANTERO MIDSTREAM CORPORATION | June 3, 2026 | To approve, on an advisory basis, the compensation of Antero Midstream Corporation's named executive officers. Say-on-Pay |
Board | For | FOR 6 funds |
Split 3 FOR, 3 ABSTAIN |
| ANTERO MIDSTREAM CORPORATION | June 3, 2026 | To ratify the appointment of KPMG LLP as Antero Midstream Corporation's independent registered public accounting firm for the year ending December 31, 2026. Audit-related |
Board | For | FOR 5 funds |
Split 3 FOR, 3 ABSTAIN |
| ANTERO RESOURCES CORPORATION | June 3, 2026 | To approve, on an advisory basis, the compensation of Antero Resources Corporation's named executive officers. Say-on-Pay |
Board | For | FOR 6 funds |
Split 3 FOR, 1 ABSTAIN |
| ANTERO RESOURCES CORPORATION | June 3, 2026 | To ratify the appointment of KPMG LLP as Antero Resources Corporation's independent registered public accounting firm for the year ending December 31, 2026. Audit-related |
Board | For | FOR 5 funds |
Split 3 FOR, 1 ABSTAIN |
| AON PLC | June 26, 2026 | Advisory resolution to approve the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 10 funds |
Split 3 FOR, 5 AGAINST, 2 ABSTAIN |
| AON PLC | June 26, 2026 | Authorize the Board or the Audit Committee of the Board to determine the remuneration of Ernst & Young Ireland, in its capacity as the Company's statutory auditor under Irish Law. Audit-related |
Board | For | FOR 9 funds |
Split 9 FOR, 2 ABSTAIN |
| AON PLC | June 26, 2026 | Authorize the Board to issue Class A Ordinary Shares under Irish Law. Capital Structure |
Board | For | FOR 9 funds |
Split 9 FOR, 2 AGAINST |
| AON PLC | June 26, 2026 | Authorize the Board to opt-out of statutory pre-emption rights under Irish Law. Capital Structure |
Board | For | FOR 9 funds |
Split 9 FOR, 2 AGAINST |
| AON PLC | June 26, 2026 | Election of Directors: Adriana Karaboutis Director Elections |
Board | For | FOR 9 funds |
Split 8 FOR, 2 ABSTAIN |
| AON PLC | June 26, 2026 | Election of Directors: Byron O. Spruell Director Elections |
Board | For | FOR 9 funds |
Split 8 FOR, 2 ABSTAIN |
| AON PLC | June 26, 2026 | Election of Directors: Cheryl A. Francis Director Elections |
Board | For | FOR 9 funds |
Split 8 FOR, 2 ABSTAIN |
| AON PLC | June 26, 2026 | Election of Directors: Gloria Santona Director Elections |
Board | For | FOR 9 funds |
Split 8 FOR, 2 ABSTAIN |
| AON PLC | June 26, 2026 | Election of Directors: Gregory C. Case Director Elections |
Board | For | FOR 9 funds |
Split 8 FOR, 2 ABSTAIN |
| AON PLC | June 26, 2026 | Election of Directors: James G. Stavridis Director Elections |
Board | For | FOR 9 funds |
Split 8 FOR, 2 ABSTAIN |
| AON PLC | June 26, 2026 | Election of Directors: Jeffrey C. Campbell Director Elections |
Board | For | FOR 9 funds |
Split 8 FOR, 2 ABSTAIN |
| AON PLC | June 26, 2026 | Election of Directors: Jin-Yong Cai Director Elections |
Board | For | FOR 9 funds |
Split 8 FOR, 2 ABSTAIN |
| AON PLC | June 26, 2026 | Election of Directors: Jo Ann Jenkins Director Elections |
Board | For | FOR 9 funds |
Split 8 FOR, 2 ABSTAIN |
| AON PLC | June 26, 2026 | Election of Directors: Jose Antonio Alvarez Director Elections |
Board | For | FOR 9 funds |
Split 3 FOR, 2 ABSTAIN |
| AON PLC | June 26, 2026 | Election of Directors: Lester B. Knight Director Elections |
Board | For | FOR 9 funds |
Split 7 FOR, 1 AGAINST, 2 ABSTAIN |
| AON PLC | June 26, 2026 | Election of Directors: Richard C. Notebaert Director Elections |
Board | For | FOR 9 funds |
Split 8 FOR, 2 ABSTAIN |
| AON PLC | June 26, 2026 | Election of Directors: Sarah E. Smith Director Elections |
Board | For | FOR 9 funds |
Split 8 FOR, 2 ABSTAIN |
| AON PLC | June 26, 2026 | Ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 9 funds |
Split 8 FOR, 1 AGAINST, 2 ABSTAIN |
| AON PLC | June 26, 2026 | Re-appoint Ernst & Young Chartered Accountants as the Company's statutory auditor under Irish Law. Audit-related |
Board | For | FOR 9 funds |
Split 8 FOR, 1 AGAINST, 2 ABSTAIN |
| APA CORPORATION | May 21, 2026 | Advisory vote to approve the compensation of APA's named executive officers Say-on-Pay |
Board | For | FOR 9 funds |
Split 5 FOR, 2 ABSTAIN |
| APA CORPORATION | May 21, 2026 | Approval of an amendment to APA's 2016 Omnibus Compensation Plan to extend its term and increase the shares authorized for issuance thereunder Compensation |
Board | For | FOR 8 funds |
Split 5 FOR, 2 ABSTAIN |
| APA CORPORATION | May 21, 2026 | Election of directors: Annell R. Bay Director Elections |
Board | For | FOR 8 funds |
Split 5 FOR, 2 ABSTAIN |
| APA CORPORATION | May 21, 2026 | Election of directors: Anya Weaving Director Elections |
Board | For | FOR 8 funds |
Split 5 FOR, 2 ABSTAIN |
| APA CORPORATION | May 21, 2026 | Election of directors: Chansoo Joung Director Elections |
Board | For | FOR 8 funds |
Split 5 FOR, 2 ABSTAIN |
| APA CORPORATION | May 21, 2026 | Election of directors: Charles W. Hooper Director Elections |
Board | For | FOR 8 funds |
Split 5 FOR, 2 ABSTAIN |
| APA CORPORATION | May 21, 2026 | Election of directors: David L. Stover Director Elections |
Board | For | FOR 8 funds |
Split 5 FOR, 2 ABSTAIN |
| APA CORPORATION | May 21, 2026 | Election of directors: H. Lamar McKay Director Elections |
Board | For | FOR 8 funds |
Split 5 FOR, 2 ABSTAIN |
| APA CORPORATION | May 21, 2026 | Election of directors: John J. Christmann IV Director Elections |
Board | For | FOR 8 funds |
Split 5 FOR, 2 ABSTAIN |
| APA CORPORATION | May 21, 2026 | Election of directors: Juliet S. Ellis Director Elections |
Board | For | FOR 8 funds |
Split 5 FOR, 2 ABSTAIN |
| APA CORPORATION | May 21, 2026 | Election of directors: Kenneth M. Fisher Director Elections |
Board | For | FOR 8 funds |
Split 5 FOR, 2 ABSTAIN |
| APA CORPORATION | May 21, 2026 | Election of directors: Peter A. Ragauss Director Elections |
Board | For | FOR 8 funds |
Split 5 FOR, 2 ABSTAIN |
| APA CORPORATION | May 21, 2026 | Ratification of appointment of Ernst & Young LLP as APA's independent auditor Audit-related |
Board | For | FOR 8 funds |
Split 5 FOR, 2 ABSTAIN |
| API GROUP CORPORATION | May 15, 2026 | To approve, on an advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 7 funds |
Split 9 FOR, 2 ABSTAIN |
| API GROUP CORPORATION | May 15, 2026 | To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the 2026 fiscal year. Audit-related |
Board | For | FOR 6 funds |
Split 9 FOR, 2 ABSTAIN |
| APOGEE THERAPEUTICS, INC. | June 9, 2026 | Approval, on a non-binding advisory basis, of the compensation of our named executive officers as disclosed in the proxy statement. Say-on-Pay |
Board | For | FOR 5 funds |
Split 6 FOR, 3 ABSTAIN |
| APOGEE THERAPEUTICS, INC. | June 9, 2026 | Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. Audit-related |
Board | For | FOR 5 funds |
Split 6 FOR, 3 ABSTAIN |
| APOLLO GLOBAL MANAGEMENT, INC. | June 8, 2026 | The ratification of the appointment of Deloitte & Touche LLP as AGM's independent registered public accounting firm for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 8 funds |
Split 4 FOR, 1 ABSTAIN |
| APPFOLIO, INC. | June 12, 2026 | Advisory vote to approve the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 6 funds |
Split 3 FOR, 2 ABSTAIN |
| APPFOLIO, INC. | June 12, 2026 | Ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 5 funds |
Split 3 FOR, 2 ABSTAIN |
| APPLE HOSPITALITY REIT, INC. | May 22, 2026 | Approval on an advisory basis of executive compensation paid by the Company. Say-on-Pay |
Board | For | FOR 5 funds |
Split 3 FOR, 1 ABSTAIN |
| APPLE HOSPITALITY REIT, INC. | May 22, 2026 | Ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm to serve for 2026. Audit-related |
Board | For | FOR 4 funds |
Split 3 FOR, 1 ABSTAIN |
| APPLE INC. | February 24, 2026 | Advisory vote to approve executive compensation Say-on-Pay |
Board | For | FOR 14 funds |
Split 11 FOR, 1 AGAINST, 8 ABSTAIN |
| APPLE INC. | February 24, 2026 | Ratification of the appointment of Ernst & Young LLP as Apple's independent registered public accounting firm for fiscal 2026 Audit-related |
Board | For | FOR 13 funds |
Split 12 FOR, 8 ABSTAIN |
| APPLE INC. | February 24, 2026 | The election to Apple's Board of Directors of the eight nominees named in the Proxy Statement Wanda Austin Director Elections |
Board | For | FOR 13 funds |
Split 10 FOR, 8 ABSTAIN |
| APPLIED DIGITAL CORPORATION | November 5, 2025 | Approve an amendment to the Company's Second Amended and Restated Articles of Incorporation, as amended, to increase the number of shares of common stock authorized for issuance thereunder by 200,000,000 shares. Capital Structure |
Board | For | FOR 2 funds |
Split 2 FOR, 1 AGAINST |
| APPLIED DIGITAL CORPORATION | November 5, 2025 | Approve the Company's 2024 Equity Compensation Plan amendment to increase the number of shares of common stock authorized for issuance by 15,000,000 shares. Compensation |
Board | For | FOR 2 funds |
Split 2 FOR, 1 ABSTAIN |
| APPLIED DIGITAL CORPORATION | November 5, 2025 | Approve, on an advisory basis, the executive compensation of the Company's named executive officers as described in the proxy statement. Say-on-Pay |
Board | For | FOR 2 funds |
Split 2 AGAINST, 1 ABSTAIN |
| APPLIED DIGITAL CORPORATION | November 5, 2025 | Ratify the appointment of CBIZ CPAs P.C. as the Company's independent registered public accounting firm for the fiscal year ending May 31, 2026. Audit-related |
Board | For | FOR 2 funds |
Split 2 FOR, 1 ABSTAIN |
| APPLIED INDUSTRIAL TECHNOLOGIES, INC. | October 21, 2025 | Election of Directors: Joe A. Raver Director Elections |
Board | For | FOR 6 funds |
Split 5 FOR, 6 WITHHOLD |
| APPLIED INDUSTRIAL TECHNOLOGIES, INC. | October 21, 2025 | Election of Directors: Mary Dean Hall Director Elections |
Board | For | FOR 6 funds |
Split 3 FOR, 8 WITHHOLD |
| APPLIED INDUSTRIAL TECHNOLOGIES, INC. | October 21, 2025 | Election of Directors: Richard J. Simoncic Director Elections |
Board | For | FOR 6 funds |
Split 5 FOR, 6 WITHHOLD |
| APPLIED INDUSTRIAL TECHNOLOGIES, INC. | October 21, 2025 | Ratification of the Audit Committee's appointment of independent auditors. Audit-related |
Board | For | FOR 6 funds |
Split 6 FOR, 5 ABSTAIN |
| APPLIED MATERIALS, INC. | March 12, 2026 | Ratification of the appointment of KPMG LLP as Applied Materials' independent registered public accounting firm for fiscal year 2026. Audit-related |
Board | For | FOR 15 funds |
Split 5 FOR, 1 AGAINST, 2 ABSTAIN |
| APPLIED OPTOELECTRONICS, INC. | June 4, 2026 | To approve, on an advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 5 funds |
Split 3 FOR, 1 ABSTAIN |
| APPLOVIN CORPORATION | June 3, 2026 | Approval, on an advisory basis, of the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 8 funds |
Split 4 FOR, 4 AGAINST, 3 ABSTAIN |
| APPLOVIN CORPORATION | June 3, 2026 | Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 7 funds |
Split 8 FOR, 3 ABSTAIN |
| APTARGROUP, INC. | May 6, 2026 | Advisory vote to approve executive compensation. Say-on-Pay |
Board | For | FOR 5 funds |
Split 4 FOR, 1 ABSTAIN |
| APTARGROUP, INC. | May 6, 2026 | Ratification of the appointment of PricewaterhouseCoopers LLP as the Independent Registered Public Accounting Firm for 2026. Audit-related |
Board | For | FOR 4 funds |
Split 4 FOR, 1 ABSTAIN |
| APTIV PLC | April 29, 2026 | Proposal to re-appoint auditors, ratify independent public accounting firm and authorize the directors to determine the fees paid to the auditors. Audit-related |
Board | For | FOR 10 funds |
Split 5 FOR, 2 ABSTAIN |
| APTIV PLC | April 29, 2026 | Say-on-Pay - To approve, by advisory vote, executive compensation. Say-on-Pay |
Board | For | FOR 11 funds |
Split 5 FOR, 2 ABSTAIN |
| ARAMARK | February 3, 2026 | To approve, in a non-binding advisory vote, the compensation paid to the named executive officers. Say-on-Pay |
Board | For | FOR 6 funds |
Split 2 FOR, 2 ABSTAIN |
| ARAMARK | February 3, 2026 | To ratify the appointment of Deloitte & Touche LLP as Aramark's independent registered public accounting firm for the fiscal year ending October 2, 2026. Audit-related |
Board | For | FOR 6 funds |
Split 2 FOR, 2 ABSTAIN |
| ARCBEST CORPORATION | April 24, 2026 | To approve the reincorporation of the Company to the State of Texas by conversion. Extraordinary Transactions |
Board | For | AGAINST 5 funds |
Split 1 FOR, 2 AGAINST, 2 ABSTAIN |
| ARCBEST CORPORATION | April 24, 2026 | To approve, on an advisory basis, the compensation of the Company's Named Executive Officers. Say-on-Pay |
Board | For | FOR 5 funds |
Split 3 FOR, 2 ABSTAIN |
← Previous Page 5 of 102 Next →
How items are matched and positions counted: see the comparison table and the methodology. Built October 25, 2026 from SEC Form N-PX filings.